Mechanistic Evaluation of Therapeutic Targets derived from Treatable
Official title: Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
Offered by Department of Health and Human Services
Award
Award varies
Estimated Application Due Date
Oct 28, 2027
Eligible Area
National
Opens
Sep 30, 2026
Overview
Funds research on modifiable mechanisms and therapeutic targets for HIV-related central nervous system complications. Fits phased studies starting with patient groups sharing disease mechanisms.
- What it funds: Research on mechanisms and therapeutic targets for HIV complications
- Focus: Central nervous system outcomes in people with HIV
- Approach: Phased research starting with patient groups sharing disease mechanisms
- Clinical trials: Not allowed
- Deadline: October 28, 2027
Who Can Apply
- Not eligible: Non-U.S. organizations
- Not eligible: Non-U.S. components of U.S. organizations
- Not allowed: Foreign components under National Institutes of Health policy
- Eligibility details: See Section III of the funding notice
Grant Details
Award Amount
Award varies
Eligible Area
National · Nationwide (federal)
Opens
Sep 30, 2026
Estimated Application Due Date
Oct 28, 2027
Contact & Funder Details
How To Apply
Apply directly on Department of Health and Human Services's website. Confirm current details before applying.
Go to the applicationThis page was last reviewed October 1, 2026 and last updated October 1, 2026.